Cytokinetics Announces Completion of Enrollment in GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure

    NEXT STORY
    Advanced Wound Dressings Market to Reach US$ 8,460.8 Mn by 2025, Increasing FDA Approvals to Enable Growth, says Fortune Business Insights
    PREV STORY
    RedHill Biopharma to Host Second Quarter 2019 Financial Results Conference Call on July 23, 2019
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Global Clinical Trials Trends and Recent Advancements Report 2019: Year Over Year Clinical Trials in Top 10 Therapy Areas, 2007-2018

    Dublin, Jan. 30, 2019 (GLOBE NEWSWIRE) -- The "Global Clinical Trials - Current Trends ...

    author_avatar
    NASDAQ Market News

    Cesca Therapeutics Announces Second Quarter 2018 Financial Results and Provides Corporate Update

    Conference Call to be Held at 4:30 p.m. ET (1:30 p.m. PT)RANCHO CORDOVA, Calif., ...

    author_avatar
    NASDAQ Market News

    Celyad Announces Commercial License Agreement for C-Cure(R) in Greater China

    All costs leading to market approval to be paid by local partner New agreement ...

    author_avatar
    NASDAQ Market News